Universal-Beteiligungs- und Servicegesellschaft’s Eledon Pharmaceuticals ELDN Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49.9K	Buy	+12,662	New	+$46K	﹤0.01%	2106

Other funds holding ELDN

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's ELDN Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 12,662 shares worth $49.9K. The stake represents ﹤0.01% of the portfolio and ranks #2106 among its holdings.

160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 12,662 shares of Eledon Pharmaceuticals worth $49.9K as of Q2 2026.
Eledon Pharmaceuticals was a new Universal-Beteiligungs- und Servicegesellschaft position in Q2 2026.
Eledon Pharmaceuticals made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #2106 holding.
160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.